The effect of duodenojejunostomy and sleeve gastrectomy on type 2 diabetes mellitus and gastrin secretion in Goto-Kakizaki rats. (Q51317628)

3 April 2018

title

The effect of duodenojejunostomy and sleeve gastrectomy on type 2 diabetes mellitus and gastrin secretion in Goto-Kakizaki rats. (English)

1 reference

3 April 2018

0 references

1 reference

Eivind Grong

1

1 reference

3 April 2018

Ingerid Brænne Arbo

2

1 reference

3 April 2018

Ole Kristian Forstrønen Thu

3

1 reference

3 April 2018

Esther Kuhry

4

1 reference

3 April 2018

Bård Kulseng

5

1 reference

3 April 2018

Ronald Mårvik

6

1 reference

3 April 2018

language of work or name

English

0 references

publication date

9 August 2014

1 reference

3 April 2018

published in

Surgical Endoscopy

1 reference

3 April 2018

volume

29

1 reference

3 April 2018

issue

3

1 reference

3 April 2018

page(s)

723-733

1 reference

3 April 2018

https://scigraph.springernature.com/pub.10.1007/s00464-014-3732-2

exact match

0 references

cites work

Global estimates of the prevalence of diabetes for 2010 and 2030

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Bariatric surgery versus conventional medical therapy for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Mechanism of metabolic advantages after bariatric surgery: it's all gastrointestinal factors versus it's all food restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

BMI guidelines for bariatric surgery in diabetes: how low can we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

The effect of gastrin on basal- and glucose-stimulated insulin secretion in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Molecular characterization of rat gastric mucosal response to potent acid inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Modeling diabetes disease progression and salsalate intervention in Goto-Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Mechanism-based disease progression modeling of type 2 diabetes in Goto-Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Proton pump inhibitors as a treatment method for type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Pantoprazole may improve beta cell function and diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Sleeve gastrectomy provides a better control of diabetes by decreasing ghrelin in the diabetic Goto-Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Duodenal-jejunal bypass surgery does not increase skeletal muscle insulin signal transduction or glucose disposal in Goto-Kakizaki type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Proximal duodenal-ileal end-to-side bypass with sleeve gastrectomy: proposed technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to three-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Sub-sleeve gastrectomy achieves good diabetes control without weight loss in a non-obese diabetic rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Modeling disease progression and rosiglitazone intervention in type 2 diabetic Goto-Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Gastrin Treatment Stimulates β-Cell Regeneration and Improves Glucose Tolerance in 95% Pancreatectomized Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00464-014-3732-2

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

21 January 2018

1 reference

12 December 2020

Inhibition of progressive reduction of islet beta-cell mass in spontaneously diabetic Goto-Kakizaki rats by alpha-glucosidase inhibitor

1 reference

12 December 2020

Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement

1 reference

12 December 2020

The preparation of bioactive 125I-gastrin, using Iodo-gen as oxidizing agent, and the use of this tracer in receptor studies

1 reference

12 December 2020

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

1 reference

12 December 2020

First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis

1 reference

12 December 2020

A rodent model of metabolic surgery for study of type 2 diabetes and positron emission tomography scanning of beta cell mass

1 reference

12 December 2020

End-to-side duodeno-jejunostomy with half-and-half biliopancreatic limb for the treatment of type 2 diabetes: a proposal for a simpler technique

1 reference

12 December 2020

Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1

1 reference

12 December 2020

Histologic, immunohistochemical and morphometric study of the mucosa of the total gastric antrum in patients with carcinoma of the stomach

1 reference

12 December 2020

Raising serum gastrin to improve glycemic control in (type 2) diabetes: another limb of the enteroinsular axis?

1 reference

12 December 2020

Gastrin and insulin release

1 reference

12 December 2020

10.1007/S00464-014-3732-2

Identifiers

DOI

1 reference

3 April 2018

1 reference

3 April 2018